Carlos José Rodrigues Crispim Romão

Corporate Officer/Principal at Universidade Nova de Lisboa

Consumer Services

Health Technology

Profile

Carlos José Rodrigues Crispim Romão is the founder of Proterris (Portugal) -.
Investigação e Desenvolvimento, which was founded in 2002.
He held the title of Vice President-Chemistry from 2002 to 2009.
Currently, he is a Professor at Universidade Nova de Lisboa.
In the past, he held the position of Principal at the University of Oxford and Technische Universität München.

Carlos José Rodrigues Crispim Romão active positions

Companies	Position	Start
Universidade Nova de Lisboa	Corporate Officer/Principal	2010-03-23

All active positions of Carlos José Rodrigues Crispim Romão

Former positions of Carlos José Rodrigues Crispim Romão

Companies	Position	End
Technische Universität München	Corporate Officer/Principal	-
University of Oxford	Corporate Officer/Principal	-
Proterris (Portugal) - Investigação e Desenvolvimento Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal.	Founder	-

See the detail of Carlos José Rodrigues Crispim Romão's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carlos José Rodrigues Crispim Romão's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Proterris (Portugal) - Investigação e Desenvolvimento Proterris (Portugal) - Investigação e Desenvolvimento Pharmaceuticals: GenericHealth Technology Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal.	Health Technology